BioCardia, Inc.
BCDA
$1.14
$0.043.64%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | 20.51% | -31.58% | |||
| Gross Profit | -20.51% | 31.58% | |||
| SG&A Expenses | 60.33% | -19.18% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 35.28% | -27.45% | |||
| Operating Income | -35.28% | 27.45% | |||
| Income Before Tax | -33.78% | 27.62% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -33.78% | 27.62% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -33.78% | 27.62% | |||
| EBIT | -35.28% | 27.45% | |||
| EBITDA | -35.44% | 27.47% | |||
| EPS Basic | 21.34% | 41.68% | |||
| Normalized Basic EPS | 21.34% | 41.68% | |||
| EPS Diluted | 21.34% | 41.68% | |||
| Normalized Diluted EPS | 21.34% | 41.68% | |||
| Average Basic Shares Outstanding | 70.07% | 24.07% | |||
| Average Diluted Shares Outstanding | 70.07% | 24.07% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||